Sjoqvist Nikolaj H purchased $100K of WW

WeightWatchers (WW) reported Q2 2026 revenue of $162.3 million, down 14.2% year over year, with behavioral revenue falling 22.7% to $121.5 million. Clinical end-of-period subscribers rose 55.7% to 197,000 and total subscribers fell to 2.5 million. Adjusted EBITDA was $39.8 million. 2026 guidance: revenue $620-$635 million, adjusted EBITDA $105-$115 million.

WW International (NASDAQ:WW) reported Q2 average revenue per user up 10.2% YoY. Clinical subscription revenue rose 30.4% to $39.9M, while behavioral fell 22.7% to $121.5M. Gross margin was 70.3% (adjusted 73.6%). WW ended with $101.5M cash, repaid debt, and reaffirmed 2026 revenue $620M-$635M and adjusted EBITDA $105M-$115M.

WeightWatchers (NASDAQ:WW) reported Q2 CY2026 revenue of $162.3 million, down 14.2% year on year, but 2% above Wall Street estimates, according to the company. Full-year revenue guidance is $627.5 million at the midpoint, 0.7% below analysts’ estimates. GAAP profit was $1.41 per share above consensus; shares fell 1.3% to $15.23 after the report.

WW INTERNATIONAL, INC. (WW) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Weight Watchers Announces Second Quarter 2026 Results Total End of Period Subscribers of 2.5 million; End of Period Clinical Subscribers of 197 thousand, up 55.7% year-over-year Core+ End of Period Subscribers of 541 thousand, up 13.9% year-over-year, reflecting thir

WeightWatchers (NASDAQ: WW) shares rose 6.3% in the afternoon after the company said its Weight Watchers Med+ program is now available through Eli Lilly’s digital platform, LillyDirect. The program pairs GLP-1 prescription obesity drugs with behavioral, nutritional, and lifestyle support. The stock is down 45.5% year to date, at $17.13.

SOLOWAY RICHARD (Founder and Executive Chairman) sold 475,000 shares of NAPCO SECURITY TECHNOLOGIES, INC (NSSC) at an average of $34.79 ($34.50–$35.93, $16.52M total) across 2 trades over 2026-08-26 to 2026-08-27.